Octave Bioscience

Octave Bioscience is creating disease management, clinical decision support, and patient engagement tools to improve outcomes for patients with multiple sclerosis (MS) and other neurodegenerative conditions. The platform leverages advanced imaging, analytics, patient tracking, and biomarker testing to improve the diagnostic and prescribing process. Octave Bioscience’s strategy is to focus on optimizing shared decision-making between the neurologist and patient.

MILESTONES

Founded in 2017
Partnered in 2018

BASED IN

Menlo Park, CA

CEO

William Hagstrom